Brief: CLS Files Application For Approval Of Tranberg To U.S. FDA
Jan 3 (Reuters) - Clinical Laserthermia Systems CLSRb.ST :
* SAID ON FRIDAY SUBMITTED ITS APPLICATION FOR APPROVAL TO
U.S.
FOOD AND DRUG ADMINISTRATION FOR SECOND GENERATION OF TRANBERG
Source text for Eikon: urn:newsml:reuters.com:*:nWkr9THCMK
Further company coverage: CLSRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028